NDC 68788-7850 Meclizine Hcl 25 Mg

Meclizine Hydrochloride

NDC Product Code 68788-7850

NDC CODE: 68788-7850

Proprietary Name: Meclizine Hcl 25 Mg What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Meclizine Hydrochloride What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

Product Characteristics

Color(s):
PINK (C48328 - UNCOATED)
Shape: ROUND (C48348)
Size(s):
8 MM
Imprint(s):
21G
Score: 2
Flavor(s):
RASPBERRY (C73413)

NDC Code Structure

NDC 68788-7850-1

Package Description: 10 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC

NDC 68788-7850-3

Package Description: 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC

NDC Product Information

Meclizine Hcl 25 Mg with NDC 68788-7850 is a a human over the counter drug product labeled by Preferred Pharmaceuticals Inc.. The generic name of Meclizine Hcl 25 Mg is meclizine hydrochloride. The product's dosage form is tablet, chewable and is administered via oral form.

Labeler Name: Preferred Pharmaceuticals Inc.

Dosage Form: Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Meclizine Hcl 25 Mg Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • MECLIZINE HYDROCHLORIDE 25 mg/1

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • ASPARTAME (UNII: Z0H242BBR1)
  • SUCROSE (UNII: C151H8M554)
  • CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
  • DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)
  • FD&C RED NO. 40 (UNII: WZB9127XOA)
  • MAGNESIUM STEARATE (UNII: 70097M6I30)
  • MALTODEXTRIN (UNII: 7CVR7L4A2D)
  • MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
  • SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
  • SODIUM SULFATE (UNII: 0YPR65R21J)
  • TRICALCIUM PHOSPHATE (UNII: K4C08XP666)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Oral - Administration to or by way of the mouth.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Preferred Pharmaceuticals Inc.
Labeler Code: 68788
FDA Application Number: part336 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 01-26-2021 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2022 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.

Meclizine Hcl 25 Mg Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Other

DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSINGDrug Facts

Distributed by: Plus Pharma, Commack, NY 11725 *Plus Pharma is not affiliated with the owner of the registered trademark Bonine®.

Otc - Active Ingredient

Active ingredient (in each chewable tablet)Meclizine HCl, USP 25 mg

Otc - Purpose

PurposeAntiemetic

Indications & Usage

Usesprevents and treats nausea, vomiting or dizziness due to motion sickness

Warnings

Warnings

Otc - Do Not Use

Do not use in children under 12 years of age unless directed by a doctor.

Otc - Ask Doctor

  • Ask a doctor before use if you have •glaucoma •a breathing problem such as emphysema or chronic bronchitis •trouble urinating due to an enlarged prostate gland

Otc - Ask Doctor/Pharmacist

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

Otc - When Using

  • When using this product •may cause drowsiness •alcohol, sedatives and tranquilizers may increase drowsiness •avoid alcoholic drinks •use caution when driving a motor vehicle or operating machinery

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.In case of overdose, get medical help or contact the poison control center immediately.

Dosage & Administration

  • Directions •dosage should be taken one hour before travel starts. •adults and children 12 years of age and older: Chew 1-2 tablets once daily or as directed by a doctor •children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor

Storage And Handling

  • Other information •phenylketonurics: contains phenylalanine 0.28 mg per tablet •store at room temperature in a dry place

Inactive Ingredient

Inactive ingredients Aspartame, croscarmellose sodium, dextrose, FD&C red #40 lake, magnesium stearate, maltodextrin, microcrystalline cellulose, natural and artificial flavors, silicon dioxide, sodium sulfate, sugar, tricalcium phosphate.

Otc - Questions

Questions? If you have any questions or comments or to report an adverse event, please contact (800) 795-9775.

* Please review the disclaimer below.